This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB03479/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03479/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03479/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03479/identifier/pdb/

Statements

Subject Item
n2:DB03479
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03479 n12:DB03479
dcterms:title
8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
adms:identifier
n8:GL7 n9:46936693 n10:DB03479 n11:46505966
n3:IUPAC-Name
n4:271B4C2E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C34-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C33-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C30-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C31-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C32-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C2C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C2D-363D-11E5-9242-09173F13E4C5 n4:271B4C2A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C2B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C3A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C3B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C35-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C36-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C38-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C37-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C39-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4C40-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C42-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C43-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C3F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C3E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C41-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C2F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C3C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C3D-363D-11E5-9242-09173F13E4C5